Abstract
The treatment of cutaneous leishmaniasis in associated with several adverse effects and therapeutic failure, resulting in patients’ abandonment of treatment. Research on new drugs with leishmanicidal potential from medicinal plants is essential. The anti-Leishmania activity of Tetradenia riparia essential oil (TrEO) and its derivatives, such as the diterpene 6,7-dehydroroyleanone (TrROY), and the immunomodulatory effects of TrEO have been reported. However, few studies have investigated the effects of TrROY. The present study evaluated the modulation of cytokine production by murine macrophages that were infected with Leishmania amazonensis (6 parasites/macrophage) and treated with TrROY (0.1, 1, and 100 μg/ml). Cytokine levels were measured by flow cytometry. The results were analyzed using Student’s t test at a 95% confidence interval. Microscopic counting was performed to evaluate the inhibitory effects of TrROY on intracellular infection. TrROY modulated the production of cytokines that are essential for the immune defense response to Leishmania, with a decrease in interleukin-4 (IL-4) levels and an increase in IL-12 levels. A TrROY concentration of 0.1 μg/ml was chosen for the subsequent experiments. This dose was chosen because it modulated IL-4/IL-12 release by murine macrophages that were infected with Leishmania and because it presented no cytotoxic effects. TrROY (0.1 μg/ml) induced a 31% reduction of the rate of infection in murine macrophages compared with untreated cells. TrROY may be a promising leishmanicidal agent. Further in vitro and in vivo studies should be conducted to evaluate the anti-Leishmania and immunomodulatory activity of TrROY.
This is a preview of subscription content, log in via an institution to check access.
References
Arango Duque G, Fukuda M, Turco SJ, Stäger S, Descoteaux A (2014) Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI. J Immunol 193:2363–2372. https://doi.org/10.4049/jimmunol.1303043
Argüello RJ, Rodrigues CR, Gatti E, Pierre P (2015) Protein synthesis regulation, a pillar of strength for innate immunity? Curr Opin Immunol 32:28–35. https://doi.org/10.1016/j.coi.2014.12.001
Baldin VP, Bertin De Lima Scodro R, Lopes-Ortiz MA, et al (2018) Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-Dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae). Phytomedicine in press. doi: https://doi.org/10.1016/j.phymed.2018.04.043, 47, 34, 39
Brazil (2017) Manual for surveillance of cutaneous leishmaniasis. Publisher of the Ministry of Health
Demarchi IG, de Souza Terron M, Thomazella MV et al (2015a) Immunomodulatory activity of essential oil from Tetrania riparia (Hochstetter) Codd in murine macrophages. Flavour Fragr J 30:428–438. https://doi.org/10.1002/ffj.3284
Demarchi IG, Thomazella MV, de Souza Terron M, Lopes L, Gazim ZC, Cortez DAG, Donatti L, Aristides SMA, Silveira TGV, Lonardoni MVC (2015b) Antileishmanial activity of essential oil and 6,7-dehydroroyleanone isolated from Tetradenia riparia. Exp Parasitol 157:128–137. https://doi.org/10.1016/j.exppara.2015.06.014
Demarchi IG, de Souza Terron M, Thomazella MV et al (2016) Antileishmanial and immunomodulatory effects of the essential oil from Tetradenia riparia (Hochstetter) Codd. Parasite Immunol 38:64–77. https://doi.org/10.1111/pim.12297
Gazim ZC, Amorim AC, Hovell AMC et al (2010) Seasonal variation, chemical composition, and analgesic and antimicrobial activities of the essential oil from leaves of Tetradenia riparia (Hochst.) Codd in southern Brazil. Molecules 15:5509–5524. https://doi.org/10.3390/molecules15085509
Gazim ZC, Rodrigues F, Amorin ACL, Rezende C, Soković M, Tešević V, Vučković I, Krstić G, Cortez L, Colauto N, Linde G, Cortez D (2014) New natural diterpene-type abietane from Tetradenia riparia essential oil with cytotoxic and antioxidant activities. Molecules 19:514–524. https://doi.org/10.3390/molecules19010514
Gollob KJ, Viana AG, Dutra WO (2014) Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol 36:367–376. https://doi.org/10.1111/pim.12100
Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35. https://doi.org/10.1038/nri978
Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O'Brien W, Cederbaum S, Christianson DW, Zimmermann N, Rothenberg ME, Finkelman FD (2010) Arginase I suppresses IL-12/IL-23 p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184:6438–6446. https://doi.org/10.4049/jimmunol.0902009
Iniesta V, Carcelén J, Molano I et al (2005) Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun 73:6085–6090. https://doi.org/10.1128/IAI.73.9.6085
Kusumoto N, Ashitani T, Hayasaka Y, Murayama T, Ogiyama K, Takahashi K (2009) Antitermitic activities of abietane-type diterpenes from Taxodium distichum cones. J Chem Ecol 35:635–642. https://doi.org/10.1007/s10886-009-9646-0
Lonardoni MV, Russo M, Jancar S (2000) Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun 68:6355–6361. https://doi.org/10.1128/IAI.68.11.6355-6361.2000
Mantovani A, Sozzani S, Locati M et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555. https://doi.org/10.1016/S1471-4906(02)02302-5
Marzochi MC d A, Marzochi KBF (1994) Tegumentary and visceral leishmaniases in Brazil: emerging anthropozoonosis and possibilities for their control. Cad Saude Publica 10(Suppl 2):S359–S375. https://doi.org/10.1590/S0102-311X1994000800014
Maspi N, Abdoli A, Ghaffarifar F (2016) Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Health 110:247–260. https://doi.org/10.1080/20477724.2016.1232042
Monge-Maillo B, López-Vélez R (2013) Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs 73:1889–1920. https://doi.org/10.1007/s40265-013-0132-1
Murray HW, Nathan CF (1999) Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189:741–746. https://doi.org/10.1084/jem.189.4.741
Noël W, Raes G, Ghassabeh GH et al (2004) Alternatively activated macrophages during parasite infections. Trends Parasitol 20:126–133. https://doi.org/10.1016/j.pt.2004.01.004
Okwor I, Uzonna JE (2016) Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis. Cell Immunol 309:32–36. https://doi.org/10.1016/j.cellimm.2016.06.004
Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC, Andrade CA (2011) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118:87–96. https://doi.org/10.1016/j.actatropica.2011.02.007
Oliveira WN, Ribeiro LE, Schrieffer A, Machado P, Carvalho EM, Bacellar O (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine 66:127–132. https://doi.org/10.1016/j.cyto.2013.12.016
Sen R, Chatterjee M (2011) Plant derived therapeutics for the treatment of leishmaniasis. Phytomedicine 18:1056–1069. https://doi.org/10.1016/j.phymed.2011.03.004
Shweash M, McGachy HA, Schroeder J et al (2011) Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. Mol Immunol 48:1800–1808. https://doi.org/10.1016/j.molimm.2011.05.013
Soulat D, Bogdan C (2017) Function of macrophage and parasite phosphatases in leishmaniasis. Front Immunol 8:1838. https://doi.org/10.3389/fimmu.2017.01838
Tripathi P, Singh V, Naik S (2007) Immune response to Leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol 51:229–242. https://doi.org/10.1111/j.1574-695X.2007.00311.x
Vendrame CMV, Carvalho MDT, Rios FJO, Manuli ER, Petitto-Assis F, Goto H (2007) Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand J Immunol 66:287–296. https://doi.org/10.1111/j.1365-3083.2007.01950.x
Wanasen N, Soong L (2008) L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol Res 41:15–25. https://doi.org/10.1007/s12026-007-8012-y
World Health Organization (2010) Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis. WHO Tech Rep Ser 949:22–26. https://goo.gl/6iYa7H. Accessed 5 Jan 2018
Funding
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil, supported this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Committee of Ethics in Animal Use in Experiments (CEAE) of the State University of Maringá (Paraná, Brazil; opinion nos. 133/2012 and 079/2012) to obtain cells from BALB/c mice.
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Section Editor: Sarah Hendrickx
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Terron-Monich, M.d., Demarchi, I.G., da Silva, P.R.F. et al. 6,7-Dehydroroyleanone diterpene derived from Tetradenia riparia essential oil modulates IL-4/IL-12 release by macrophages that are infected with Leishmania amazonensis. Parasitol Res 118, 369–376 (2019). https://doi.org/10.1007/s00436-018-6166-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-018-6166-2